Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL)

Clinical trial NCT07717580 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07717580
Sponsor: Peking University First Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T-Cell Lymphoma/Mycosis Fungoides Primary Cutaneous Anaplastic Large Cell Lymphoma

Start date: 2026-07-31
Primary completion: 2028-12-30
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.